BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6111824)

  • 1. Neuroendocrine tests during treatment with neuroleptic drugs: I. Plasma prolactin response to chlorpromazine challenge.
    Kolakowska T; Fraser S; Franklin M; Knox J
    Psychopharmacology (Berl); 1981; 72(3):283-5. PubMed ID: 6111824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine tests during treatment with neuroleptic drugs I. Plasma prolactin response to haloperidol challenge.
    Kolakowska T; Braddock L; Wiles D; Franklin M; Gelder M
    Br J Psychiatry; 1981 Nov; 139():400-4. PubMed ID: 6120731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of tolerance to long-term neuroleptic treatment in dopamine tuberoinfundibular system.
    Chouinard G; Annable L; Jones BD; Collu R
    Acta Psychiatr Scand; 1981 Nov; 64(5):353-62. PubMed ID: 6126066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum prolactin response to chlorpromazine and psychopathology in schizophrenics: implications for the dopamine hypothesis.
    Meltzer HY; Busch D
    Psychiatry Res; 1983 Aug; 9(4):285-99. PubMed ID: 6580661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine tests during treatment with neuroleptic drugs. III. Plasma growth hormone and prolactin responses to apomorphine.
    Kolakowska T; Gelder M; Fraser S
    Br J Psychiatry; 1981 Nov; 139():408-12. PubMed ID: 6120733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine serotonergic and dopaminergic responsivity in male schizophrenic patients during treatment with neuroleptics and after switch to risperidone.
    Markianos M; Hatzimanolis J; Lykouras L
    Psychopharmacology (Berl); 2001 Aug; 157(1):55-9. PubMed ID: 11512043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum prolactin levels following intramuscular chlorpromazine: two- and three-hour response as predictors of six-hour response.
    Busch DA; Fang VS; Meltzer HY
    Psychiatry Res; 1979 Oct; 1(2):153-9. PubMed ID: 45130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin secretion response to TRH stimulation in acute and chronic schizophrenic patients under neuroleptic treatment.
    Cabranes JA; Fuentenebro F; Recio MN; Borque M; Almoguera MI
    Int Pharmacopsychiatry; 1982; 17(1):1-7. PubMed ID: 6123489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of plasma chlorpromazine levels. II. Plasma levels of the drug, some of its metabolites and prolactin in patients receiving long-term phenothiazine treatment.
    Kolakowska T; Wiles DH; Gelder MG; McNeilly AS
    Psychopharmacology (Berl); 1976 Aug; 49(1):101-7. PubMed ID: 8814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of plasma drug and prolactin levels during acute chlorpromazine treatment: a replication study.
    Kolakowska T; Orr M; Gelder M; Heggie M; Wiles D; Franklin M
    Br J Psychiatry; 1979 Oct; 135():352-9. PubMed ID: 519119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance to the prolactin-elevating effect of neuroleptics.
    Brown WA; Laughren TP
    Psychiatry Res; 1981 Dec; 5(3):317-22. PubMed ID: 6119716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum neuroleptic and prolactin levels in schizophrenic patients and clinical response.
    Meltzer HY; Busch DA; Fang VS
    Psychiatry Res; 1983 Aug; 9(4):271-83. PubMed ID: 6580660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine tests during treatment with neuroleptic drugs. II. The TRH test.
    Braddock LE; Blake IM
    Br J Psychiatry; 1981 Nov; 139():404-7. PubMed ID: 6120732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in plasma prolactin levels in patients with schizophrenia treated on monotherapy with five second-generation antipsychotics.
    Suzuki Y; Sugai T; Fukui N; Watanabe J; Ono S; Tsuneyama N; Saito M; Someya T
    Schizophr Res; 2013 Apr; 145(1-3):116-9. PubMed ID: 23375624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intramuscular chlorpromazine on serum prolactin levels in schizophrenic patients and normal controls.
    Meltzer HY; Busch DA; Creese IR; Snyder SH; Fang VS
    Psychiatry Res; 1981 Aug; 5(1):95-105. PubMed ID: 6944710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in serum prolactin after electroconvulsive and epileptic seizures.
    Johansson F; von Knorring L
    Eur Arch Psychiatry Neurol Sci; 1987; 236(5):312-8. PubMed ID: 2888653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurochemical studies on tardive dyskinesia. I. Urinary homovanillic acid and plasma prolactin.
    Tripodianakis J; Markianos M; Garelis E
    Biol Psychiatry; 1983 Mar; 18(3):337-45. PubMed ID: 6132625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible associations among plasma prolactin levels, tardive dyskinesia, and paranoia in treated male schizophrenics.
    Csernansky JG; Prosser E; Kaplan J; Mahler E; Berger PA; Hollister LE
    Biol Psychiatry; 1986 Jun; 21(7):632-42. PubMed ID: 2871874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of long-term neuroleptic treatment on prolactin and norepinephrine levels in serum of chronic schizophrenics: relations to psychopathology and extrapyramidal symptoms.
    Naber D; Finkbeiner C; Fischer B; Zander KJ; Ackenheil M
    Neuropsychobiology; 1980; 6(4):181-9. PubMed ID: 6104798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High plasma prolactin levels after long-term neuroleptic treatment.
    Zelaschi NM; Delucchi GA; Rodriguez JL
    Biol Psychiatry; 1996 May; 39(10):900-1. PubMed ID: 8860193
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.